Treatment with the dual-incretin agonist DA-CH5 demonstrates potent therapeutic effect in a rat model of Wolfram SyndromeToomas Jagomäe, Mario Plaas, Marko Pastak et al.|Frontiers in Endocrinology|2023Cited by 3
GABA and GLP-1 receptor agonist combination therapy modifies diabetes and Langerhans islet cytoarchitecture in a rat model of Wolfram syndromeToomas Jagomäe, Mario Plaas, Sandra Velling et al.|Diabetology & Metabolic Syndrome|2025Cited by 3